我們已在上線!
進一步了解
CDAK
Codiak BioSciences
CDAK
CDAK
已下市
CDAK已於2023年4月4日下市。
公司簡介: Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.
員工: 53
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於CDAK的最新新聞文章。
價格圖表採用Lightweight Charts™實作